Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.10
-0.0299-2.65%
Last update: May 14, 12:53 PM
Phio Pharmaceuticals Corp Analyst Ratings
PHIONASDAQ
Earnings: Q1 2026 Earnings were released on Thu May 7th, after the market close
Phio Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:PHIO | Benzinga
Phio Pharmaceuticals Corp has a consensus price target of $10.67 based on the ratings of 3 analysts. The high is $14 issued by HC Wainwright & Co. on February 10, 2026. The low is $4 issued by HC Wainwright & Co. on April 8, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on February 10, 2026, August 15, 2025, and June 25, 2025, respectively. With an average price target of $14 between HC Wainwright & Co., there's an implied 1172.61% upside for Phio Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
HC Wainwright & Co.
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Phio Pharmaceuticals
Loading calendar...
FAQ
What is the target price for Phio Pharmaceuticals (PHIO) stock?
The latest price target for Phio Pharmaceuticals (NASDAQ:PHIO) was reported by HC Wainwright & Co. on February 10, 2026. The analyst firm set a price target for $14.00 expecting PHIO to rise to within 12 months (a possible 1172.61% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Phio Pharmaceuticals (PHIO)?
The latest analyst rating for Phio Pharmaceuticals (NASDAQ:PHIO) was provided by HC Wainwright & Co., and Phio Pharmaceuticals reiterated their buy rating.
When was the last upgrade for Phio Pharmaceuticals (PHIO)?
There is no last upgrade for Phio Pharmaceuticals
When was the last downgrade for Phio Pharmaceuticals (PHIO)?
There is no last downgrade for Phio Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Phio Pharmaceuticals (PHIO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Phio Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Phio Pharmaceuticals was filed on February 10, 2026 so you should expect the next rating to be made available sometime around February 10, 2027.
Is the Analyst Rating Phio Pharmaceuticals (PHIO) correct?
While ratings are subjective and will change, the latest Phio Pharmaceuticals (PHIO) rating was a reiterated with a price target of $14.00 to $14.00. The current price Phio Pharmaceuticals (PHIO) is trading at is $1.10, which is out of the analyst’s predicted range.
